| Year |
Citation |
Score |
| 2018 |
Tan SY, Najita J, Li X, Strazzulla LC, Dunbar H, Lee MY, Seery VJ, Buchbinder EI, Tawa NE, McDermott DF, Lee SJ, Atkins MB, Kim CC. Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients. Melanoma Research. PMID 30169431 DOI: 10.1097/Cmr.0000000000000483 |
0.336 |
|
| 2016 |
Gray SW, Park ER, Najita J, Martins Y, Traeger L, Bair E, Gagne J, Garber J, Jänne PA, Lindeman N, Lowenstein C, Oliver N, Sholl L, Van Allen EM, Wagle N, et al. Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 26866579 DOI: 10.1038/Gim.2015.207 |
0.34 |
|
| 2015 |
Dang C, Guo H, Najita J, Yardley D, Marcom K, Albain K, Rugo H, Miller K, Ellis M, Shapira I, Wolff AC, Carey LA, Moy B, Groarke J, Moslehi J, et al. Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative, ERBB2-Positive Breast Cancer. Jama Oncology. 1-8. PMID 26539793 DOI: 10.1001/Jamaoncol.2015.3709 |
0.433 |
|
| 2015 |
Seah DS, Scott S, Guo H, Najita J, Lederman R, Frank E, Sohl J, Stadler Z, Silverman S, Peppercorn J, Winer E, Come S, Lin NU. Variation in the Attitudes of Medical Oncologists Toward Research Biopsies in Patients With Metastatic Breast Cancer. The Oncologist. 20: 992-1000. PMID 26240134 DOI: 10.1634/Theoncologist.2015-0112 |
0.41 |
|
| 2015 |
Lin NU, Guo H, Yap JT, Mayer IA, Falkson CI, Hobday TJ, Dees EC, Richardson AL, Nanda R, Rimawi MF, Ryabin N, Najita JS, Barry WT, Arteaga CL, Wolff AC, et al. Phase II Study of Lapatinib in Combination With Trastuzumab in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Clinical Outcomes and Predictive Value of Early [18F]Fluorodeoxyglucose Positron Emission Tomography Imaging (TBCRC 003). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 26169615 DOI: 10.1200/Jco.2014.60.0353 |
0.356 |
|
| 2015 |
Mayer EL, Gropper AB, Harris L, Gold JM, Parker L, Kuter I, Come S, Najita JS, Guo H, Winer EP, Burstein HJ. Long-term follow-up after preoperative trastuzumab and chemotherapy for HER2-overexpressing breast cancer. Clinical Breast Cancer. 15: 24-30. PMID 25205424 DOI: 10.1016/J.Clbc.2014.07.010 |
0.434 |
|
| 2015 |
Seah DS, Scott S, Guo H, Najita J, Lederman R, Frank E, Sohl J, Stadler Z, Silverman S, Peppercorn J, Winer E, Come S, Lin NU. Variation in the attitudes of medical oncologists toward research biopsies in patients with metastatic breast cancer Oncologist. 20: 992-1000. DOI: 10.1634/theoncologist.2015-0112 |
0.31 |
|
| 2015 |
Seah DS, Scott S, Guo H, Najita J, Lederman R, Frank E, Sohl J, Stadler Z, Silverman SG, Peppercorn J, Winer EP, Come SE, Lin NU. Abstract P4-17-01: Attitudes of medical oncologists towards research breast biopsies in patients with newly diagnosed stage I-III breast cancer not enrolled in a clinical trial Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-17-01 |
0.447 |
|
| 2014 |
Gray SW, Wagle N, Garber JE, Rainville IR, Hiller E, Martins Y, Oliver N, Lowenstein C, Najita JS, VanAllen E, Janne PA, Sholl LM, Lindeman NI, Garraway LA, Joffe S. Cancer patients’ preferences for return of somatic and germline whole-exome sequencing results: Data from the CANSEQ study. Journal of Clinical Oncology. 32: 1535-1535. DOI: 10.1200/Jco.2014.32.15_Suppl.1535 |
0.333 |
|
| 2013 |
Barton SE, Najita JS, Ginsburg ES, Leisenring WM, Stovall M, Weathers RE, Sklar CA, Robison LL, Diller L. Infertility, infertility treatment, and achievement of pregnancy in female survivors of childhood cancer: a report from the Childhood Cancer Survivor Study cohort. The Lancet. Oncology. 14: 873-81. PMID 23856401 DOI: 10.1016/S1470-2045(13)70251-1 |
0.311 |
|
| 2013 |
Tolaney SM, Najita J, Sperinde J, Huang W, Chen WY, Savoie J, Fornier M, Winer EP, Bunnell C, Krop IE. A phase II study of ixabepilone and trastuzumab for metastatic HER2-positive breast cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 24: 1841-7. PMID 23559151 DOI: 10.1093/Annonc/Mdt121 |
0.404 |
|
| 2013 |
Seah DS, Scott SM, Najita J, Openshaw T, Krag K, Frank E, Sohl J, Stadler ZK, Garrett M, Silverman SG, Peppercorn J, Winer EP, Come SE, Lin NU. Attitudes of patients with metastatic breast cancer toward research biopsies. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: 1853-9. PMID 23493137 DOI: 10.1093/Annonc/Mdt067 |
0.374 |
|
| 2013 |
Olson EM, Najita JS, Sohl J, Arnaout A, Burstein HJ, Winer EP, Lin NU. Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era. Breast (Edinburgh, Scotland). 22: 525-31. PMID 23352568 DOI: 10.1016/J.Breast.2012.12.006 |
0.453 |
|
| 2013 |
Najita JS, Catalano PJ. On determining the BMD from multiple outcomes in developmental toxicity studies when one outcome is intentionally missing. Risk Analysis : An Official Publication of the Society For Risk Analysis. 33: 1500-9. PMID 23231656 DOI: 10.1111/J.1539-6924.2012.01939.X |
0.458 |
|
| 2013 |
Seah D, Scott S, Guo H, Najita J, Lederman R, Frank E, Sohl J, Kronwitz C, Stadler Z, Silverman S, Peppercorn J, Winer E, Come S, Lin N. Abstract P4-19-01: Attitudes of medical oncologists towards research biopsies Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P4-19-01 |
0.387 |
|
| 2012 |
Ligibel JA, Meyerhardt J, Pierce JP, Najita J, Shockro L, Campbell N, Newman VA, Barbier L, Hacker E, Wood M, Marshall J, Paskett E, Shapiro C. Impact of a telephone-based physical activity intervention upon exercise behaviors and fitness in cancer survivors enrolled in a cooperative group setting. Breast Cancer Research and Treatment. 132: 205-13. PMID 22113257 DOI: 10.1007/S10549-011-1882-7 |
0.344 |
|
| 2012 |
Olson EM, Lin NU, Dipiro PJ, Najita JS, Krop IE, Winer EP, Burstein HJ. Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer Annals of Oncology. 23: 93-97. PMID 21531783 DOI: 10.1093/Annonc/Mdr061 |
0.387 |
|
| 2012 |
Seah D, Scott S, Najita J, Openshaw T, Krag K, Frank E, Sohl J, Stadler Z, Garrett M, Winer E, Come S, Lin N. Abstract P2-16-04: Attitudes of metastatic breast cancer patients towards research biopsies Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-P2-16-04 |
0.415 |
|
| 2012 |
Barton S, Najita J, Ginsburg E, Diller L. Infertility and the utilization of infertility treatment in female survivors of childhood cancer: a report from the childhood cancer survivor study (CCSS) Fertility and Sterility. 98: S8. DOI: 10.1016/J.Fertnstert.2012.07.029 |
0.348 |
|
| 2011 |
Olson EM, Najita JS, Sohl J, Arnaout A, Winer EP, Lin NU. Predictors of survival in patients with HER2+ metastatic breast cancer (MBC) treated with trastuzumab. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e11100. PMID 28024068 DOI: 10.1200/Jco.2011.29.15_Suppl.E11100 |
0.409 |
|
| 2011 |
Gropper A, Burstein HJ, Harris L, Anderson KS, Gold JM, Younger WJ, Bunnell CA, Najita JS, Winer EP, Mayer EL. Long-term outcomes after neoadjuvant trastuzumab and chemotherapy for HER2+ breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: e11074. PMID 28023110 DOI: 10.1200/Jco.2011.29.15_Suppl.E11074 |
0.418 |
|
| 2011 |
Krop IE, Flores L, Najita JS, Mayer IA, Hobday TJ, Falkson CI, Arteaga CL, Wolff AC, Dees EC, Rimawi MF, Nanda R, Josephs K, Lin NU, Winer EP. The role of EGFR amplification in trastuzumab resistance: A correlative analysis of TBCRC003. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 528. PMID 28021333 DOI: 10.1200/Jco.2011.29.15_Suppl.528 |
0.331 |
|
| 2011 |
Dominici L, Najita J, Hughes M, Niland J, Marcom P, Wong YN, Carter B, Javid S, Edge S, Burstein H, Golshan M. Surgery of the primary tumor does not improve survival in stage IV breast cancer. Breast Cancer Research and Treatment. 129: 459-65. PMID 21713372 DOI: 10.1007/S10549-011-1648-2 |
0.441 |
|
| 2011 |
Olson E, Flores L, Najita J, Curley C, Jeong J, Murray K, Savoie J, Winer E, Krop I. PD05-07: Prospective Validation and Characterization of HER2 Positive Circulating Tumor Cells in Patients with HER2 Negative Metastatic Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-Pd05-07 |
0.419 |
|
| 2011 |
Dang C, Tolaney S, Najita J, Gelman R, Yardley D, Marcom K, Albain K, Rugo H, Miller K, Ellis M, Shapira I, Wolff A, Carey L, Vahdat L, Burdette-Radoux S, et al. P2-18-02: Cardiac Outcomes of Patients on Adjuvant Weekly Paclitaxel (T) and Trastuzumab (H) for Node Negative, HER2 Positive Breast Cancer (BCA). Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-18-02 |
0.342 |
|
| 2011 |
Yap J, Locascio T, Najita J, Mayer I, Hobday T, Falkson C, Dees E, Gelman R, Rimawi M, Nanda R, Berkowitz J, Franchetti Y, Wolff A, Winer E, Lin N, et al. P2-09-07: Metabolic Response by FDG-PET in Patients (pts) Receiving Trastuzumab (T) and Lapatinib (L) for HER2+ Metastatic Breast Cancer (MBC): Correlative Analysis of TBCRC 003. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P2-09-07 |
0.314 |
|
| 2010 |
McCullough L, Ng A, Najita J, Janov A, Henderson T, Mauch P, Diller L. Breastfeeding in survivors of Hodgkin lymphoma treated with chest radiotherapy. Cancer. 116: 4866-71. PMID 20629028 DOI: 10.1002/Cncr.25442 |
0.348 |
|
| 2010 |
Recklitis CJ, Diller LR, Li X, Najita J, Robison LL, Zeltzer L. Suicide ideation in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 655-61. PMID 19841325 DOI: 10.1200/Jco.2009.22.8635 |
0.317 |
|
| 2010 |
Krop IE, Flores L, Tuck DP, Ryan PD, Partridge AH, Morganstern D, Najita J, lezon-Geyda K, Winer EP, Harris L. Phase II trial of preoperative vinorelbine/trastuzumab (VH) or docetaxel/carboplatin/trastuzumab (TCH) in HER2-positive breast cancer with analysis of resistance mechanisms. Journal of Clinical Oncology. 28: 549-549. DOI: 10.1200/Jco.2010.28.15_Suppl.549 |
0.364 |
|
| 2010 |
Olson E, Lin N, DiPiro P, Najita J, Krop I, Winer E, Burstein H. Abstract P3-14-08: Responses to Subsequent Anti-HER2 Therapy after Treatment with Trastuzumab-DM1 in Women with HER2-Positive Metastatic Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-14-08 |
0.399 |
|
| 2009 |
Gold JM, Najita JS, Lester S, Richardson AL, Morganstern DE, Chen WY, Partridge AH, Krop IE, Winer EP, Burstein HJ. Personalizing treatment in early-stage breast cancer: The role of standard clinical factors and genomic information in adjuvant chemotherapy decision making. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 572. PMID 27960736 DOI: 10.1200/Jco.2009.27.15_Suppl.572 |
0.367 |
|
| 2009 |
Najita JS, Li Y, Catalano PJ. A Novel Application of a Bivariate Regression Model for Binary and Continuous Outcomes to Studies of Fetal Toxicity. Journal of the Royal Statistical Society. Series C, Applied Statistics. 58: 555-573. PMID 20357904 DOI: 10.1111/J.1467-9876.2009.00667.X |
0.456 |
|
| 2009 |
Anderson K, Hodi F, Sasada T, Canning C, Hassett M, Mayer E, Hannagan K, Wong J, Colson Y, Shoji B, Najita J, Sibani S, LaBaer J, Winer E, Dranoff G. A phase I study of an autologous GM-CSF-secreting breast cancer vaccine. Cancer Research. 69: 4124. DOI: 10.1158/0008-5472.Sabcs-4124 |
0.318 |
|
| 2009 |
Tolaney S, Najita J, Chen W, Savoie J, Fornier M, Krop I, Winer E, Bunnell C. A phase II study of ixabepilone plus trastuzumab for metastatic HER2-positive breast cancer. Cancer Research. 69: 3137. DOI: 10.1158/0008-5472.Sabcs-3137 |
0.471 |
|
| 2008 |
Tolaney SM, Najita J, Winer EP, Burstein HJ. Lymphopenia associated with adjuvant anthracycline/ taxane regimens. Clinical Breast Cancer. 8: 352-6. PMID 18757263 DOI: 10.3816/Cbc.2008.N.041 |
0.377 |
|
| Show low-probability matches. |